Terms: = Lung cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254
91 results:
1. Expansion of targeted degradation by Gilteritinib-Warheaded PROTACs to ALK fusion proteins.
Yokoo H; Tsuji G; Inoue T; Naito M; Demizu Y; Ohoka N
Bioorg Chem; 2024 Apr; 145():107204. PubMed ID: 38377822
[TBL] [Abstract] [Full Text] [Related]
2. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
[TBL] [Abstract] [Full Text] [Related]
3. npm3 as an Unfavorable Prognostic Biomarker Involved in Oncogenic Pathways of lung Adenocarcinoma
Chen L; Yang D; Huang F; Xu W; Luo X; Mei L; He Y
Comb Chem High Throughput Screen; 2024; 27(2):203-213. PubMed ID: 37114782
[TBL] [Abstract] [Full Text] [Related]
4. DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.
Dillon LW; Gui G; Page KM; Ravindra N; Wong ZC; Andrew G; Mukherjee D; Zeger SL; El Chaer F; Spellman S; Howard A; Chen K; Auletta J; Devine SM; Jimenez Jimenez AM; De Lima MJG; Litzow MR; Kebriaei P; Saber W; Weisdorf DJ; Hourigan CS
JAMA; 2023 Mar; 329(9):745-755. PubMed ID: 36881031
[TBL] [Abstract] [Full Text] [Related]
5. An Update on FLT3 in Acute Myeloid Leukemia: Pathophysiology and Therapeutic Landscape.
Bystrom R; Levis MJ
Curr Oncol Rep; 2023 Apr; 25(4):369-378. PubMed ID: 36808557
[TBL] [Abstract] [Full Text] [Related]
6. Observation of Alectinib- and Crizotinib- included chemotherapy in children with ALK-positive anaplastic large cell lymphoma: A single institutional experience.
He Y; Pei K; Zhang H; Wang J; Su X; Gan W; Wang P
Cancer Med; 2023 Mar; 12(6):7182-7188. PubMed ID: 36408869
[TBL] [Abstract] [Full Text] [Related]
7. Reassessing pharmacogenomic cell sensitivity with multilevel statistical models.
Ploenzke M; Irizarry R
Biostatistics; 2023 Oct; 24(4):901-921. PubMed ID: 35277956
[TBL] [Abstract] [Full Text] [Related]
8. De novo generation of the npm-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells.
Babin L; Darchen A; Robert E; Aid Z; Borry R; Soudais C; Piganeau M; De Cian A; Giovannangeli C; Bawa O; Rigaud C; Scoazec JY; Couronné L; Veleanu L; Cieslak A; Asnafi V; Sibon D; Lamant L; Meggetto F; Mercher T; Brunet E
Mol Cancer; 2022 Mar; 21(1):65. PubMed ID: 35246138
[TBL] [Abstract] [Full Text] [Related]
9. PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.
Choudhury RH; Symonds P; Paston SJ; Daniels I; Cook KW; Gijon M; Metheringham RL; Brentville VA; Durrant LG
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35140112
[TBL] [Abstract] [Full Text] [Related]
10. What is the likelihood of nonpulmonary metastasis occurring in the absence of lung metastasis in bone and soft tissue sarcoma? A nested case-control from a sarcoma referral centre.
Hasan O; Nasir M; Jessar M; Hashimi M; An Q; Miller BJ
J Surg Oncol; 2021 Dec; 124(8):1491-1498. PubMed ID: 34382687
[TBL] [Abstract] [Full Text] [Related]
11. npm1 Is a Prognostic Biomarker Involved in Immune Infiltration of lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract] [Full Text] [Related]
12. Discovering Panel of Autoantibodies for Early Detection of lung cancer Based on Focused Protein Array.
Jiang D; Zhang X; Liu M; Wang Y; Wang T; Pei L; Wang P; Ye H; Shi J; Song C; Wang K; Wang X; Dai L; Zhang J
Front Immunol; 2021; 12():658922. PubMed ID: 33968062
[TBL] [Abstract] [Full Text] [Related]
13. Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin.
Sutton EC; DeRose VJ
J Biol Chem; 2021; 296():100633. PubMed ID: 33819479
[TBL] [Abstract] [Full Text] [Related]
14. A KRAS-responsive long non-coding RNA controls microRNA processing.
Shi L; Magee P; Fassan M; Sahoo S; Leong HS; Lee D; Sellers R; Brullé-Soumaré L; Cairo S; Monteverde T; Volinia S; Smith DD; Di Leva G; Galuppini F; Paliouras AR; Zeng K; O'Keefe R; Garofalo M
Nat Commun; 2021 Apr; 12(1):2038. PubMed ID: 33795683
[TBL] [Abstract] [Full Text] [Related]
15. Targeting npm1 in irradiated cells inhibits npm1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC.
Traver G; Sekhar KR; Crooks PA; Keeney DS; Freeman ML
Cancer Lett; 2021 Mar; 500():220-227. PubMed ID: 33358698
[TBL] [Abstract] [Full Text] [Related]
16. Minimal Residual Disease Monitoring Using a 3'ALK Universal Probe Assay in ALK-Positive Anaplastic Large-Cell Lymphoma: ddPCR, an Attractive Alternative Method to Real-Time Quantitative PCR.
Quelen C; Grand D; Sarot E; Brugières L; Sibon D; Pradines A; Laurent C; Brousset P; Lamant L
J Mol Diagn; 2021 Feb; 23(2):131-139. PubMed ID: 33246076
[TBL] [Abstract] [Full Text] [Related]
17. Nucleophosmin 1 overexpression correlates with
Zhou LM; Yuan LL; Gao Y; Liu XS; Dai Q; Yang JW; Pei ZJ
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):904-912. PubMed ID: 32856112
[TBL] [Abstract] [Full Text] [Related]
18. Epigenetic CRISPR Screens Identify
Li F; Ng WL; Luster TA; Hu H; Sviderskiy VO; Dowling CM; Hollinshead KER; Zouitine P; Zhang H; Huang Q; Ranieri M; Wang W; Fang Z; Chen T; Deng J; Zhao K; So HC; Khodadadi-Jamayran A; Xu M; Karatza A; Pyon V; Li S; Pan Y; Labbe K; Almonte C; Poirier JT; Miller G; Possemato R; Qi J; Wong KK
Cancer Res; 2020 Sep; 80(17):3556-3567. PubMed ID: 32646968
[TBL] [Abstract] [Full Text] [Related]
19. Dactinomycin in acute myeloid leukemia with npm1 mutations.
Beziat G; Tavitian S; Bertoli S; Huguet F; Largeaud L; Luquet I; Vergez F; Rieu JB; Bories P; Delabesse E; Récher C
Eur J Haematol; 2020 Sep; 105(3):302-307. PubMed ID: 32452083
[TBL] [Abstract] [Full Text] [Related]
20. Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance.
Sun N; Ren C; Kong Y; Zhong H; Chen J; Li Y; Zhang J; Zhou Y; Qiu X; Lin H; Song X; Yang X; Jiang B
Eur J Med Chem; 2020 May; 193():112190. PubMed ID: 32179332
[TBL] [Abstract] [Full Text] [Related]
[Next]
